18 November 2017
News and Views
Links and Services
Dynamic changes of the inflammation-based index predict mortality following chemoembolization for hepatocellular carcinoma, reports this month's Alimentary Pharmacology & Therapeutics.
Transarterial chemoembolization is a standard treatment for unresectable, intermediate stage hepa
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors